Literature DB >> 16675912

Germline mutations of the PTCH gene in families with odontogenic keratocysts and nevoid basal cell carcinoma syndrome.

Ya-Ling Song1, Wen-Feng Zhang, Bin Peng, Chang-Ning Wang, Qing Wang, Zhuan Bian.   

Abstract

BACKGROUND/AIMS: Odontogenic keratocysts (OKC) are aggressive lesions in the jaws, which can occur as isolated cases or in association with nevoid basal cell carcinoma syndrome (NBCCS). Mutations on PTCH gene have been identified in patients with NBCCS. It was hypothesized that PTCH mutations may be causative in isolated OKC. This study aims to investigate germline mutations of PTCH in families with OKC and NBCCS.
METHODS: Three Chinese families with OKC and NBCCS were enrolled in the study. The diagnosis was based on examination and medical history. Mutation analysis was performed by amplifying all exons of PTCH and sequencing the products.
RESULTS: One family with isolated OKC (family 1) and the other two families with NBCCS were diagnosed. Three novel germline mutations in PTCH were identified, including a missense mutation (p.S1089 > P) in family 1, a nonsense mutation (p.Q160X) in family 2 and a de novo mutation (c.768_777delGACAAACTTC) in family 3.
CONCLUSIONS: It is proposed that isolated OKC can be inherited in an autosomal dominant mode. The results suggest that germline mutations on PTCH can cause isolated OKC, and that the PTCH gene responsible for NBCCS plays an important role in the formation of OKCs even when they are not syndrome-related. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675912     DOI: 10.1159/000093054

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.

Authors:  John M Wright; Marilena Vered
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 2.  Odontogenic tumors, WHO 2005: where do we go from here?

Authors:  John M Wright; Edward W Odell; Paul M Speight; Takashi Takata
Journal:  Head Neck Pathol       Date:  2014-11-20

3.  Conservative surgical treatments for nonsyndromic odontogenic keratocysts: a systematic review and meta-analysis.

Authors:  Mayara Santos de Castro; Clenivaldo Alves Caixeta; Marina Lara de Carli; Noé Vital Ribeiro Júnior; Marta Miyazawa; Alessandro Antônio Costa Pereira; Felipe Fornias Sperandio; João Adolfo Costa Hanemann
Journal:  Clin Oral Investig       Date:  2017-12-20       Impact factor: 3.573

Review 4.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

5.  Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins.

Authors:  Yasuyuki Shimada; Yutaka Maruoka; Iena Yamaji; Shigeo Kawai
Journal:  J Clin Diagn Res       Date:  2016-08-01

6.  Analysis of mutation in exon 17 of PTCH in patients with nevoid basal cell carcinoma syndrome.

Authors:  Jichen Li; Jinhui Wang; Yingqun Liu; Wei Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

7.  Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma.

Authors:  Chuan Bian Lim; Cecilia M Prêle; Hui Min Cheah; Yuen Yee Cheng; Sonja Klebe; Glen Reid; D Neil Watkins; Svetlana Baltic; Philip J Thompson; Steven E Mutsaers
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 8.  Gorlin-Goltz syndrome--a medical condition requiring a multidisciplinary approach.

Authors:  Małgorzata Kiwilsza; Katarzyna Sporniak-Tutak
Journal:  Med Sci Monit       Date:  2012-09

9.  Nevoid Basal Cell Carcinoma Syndrome: PTCH1 Mutation Profile and Expression of Genes Involved in the Hedgehog Pathway in Argentinian Patients.

Authors:  Maria Florencia Martinez; Maria Vanesa Romano; Alfredo Pedro Martinez; Abel González; Carolina Muchnik; Fernando Miguel Stengel; Luis Daniel Mazzuoccolo; Pablo Javier Azurmendi
Journal:  Cells       Date:  2019-02-11       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.